Hear from other medical professionals who treat atopic dermatitis

DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids.

Please view entire video for clinical trial efficacy and safety data and for full Important Safety Information.

Providers are paid consultants.

Hear from DUPIXENT patients

Actual patients treated with DUPIXENT. Individual results may vary.

Download helpful resources about DUPIXENT for uncontrolled moderate-to-severe atopic dermatitis

ADOLESCENTS (AGED 12-17 YEARS) TREATED WITH DUPIXENT

CHILDREN (AGED 6-11 YEARS)
TREATED WITH DUPIXENT

INFANTS TO PRESCHOOLERS
(AGED 6 MONTHS TO 5 YEARS)
PATIENT PROFILES

DOSING INFORMATION
FOR DUPIXENT
 

Mark your calendars for
these future events

The Society for Pediatric Dermatology 2023 Annual Meeting

July 13-16, 2023
Asheville, NC

American Academy of Dermatology Innovation Academy Meeting

August 10-13, 2023
Tampa, FL

American College of Allergy, Asthma & Immunology Annual Scientific Meeting November 9-13, 2023
Anaheim, CA

DUPIXENT MyWay is a patient support program that can help enable access
to DUPIXENT and offers financial assistance for eligible patients, one-on-one
nursing support, and more.

DUPIXENT MyWay
ENROLLMENT FORMS

FOR DERMATOLOGISTS
English Enrollment Form
Spanish Enrollment Form
FOR ALLERGISTS
English Enrollment Form
Spanish Enrollment Form